Diabetes Evidence Flashcards

1
Q

How was the [type 1] diabetes control & complications trial conducted?

A
  • Primary prevention cohort: T1DM for 1-5 years, nil retinopathy, urinary albumin excretion <40mg/24h
  • Secondary intervention cohort: T1DM for 1-15 years, mild-mod non-proliferative retinopathy, urinary albumin excretion <200mg/24h
  • 711 received insulin >3 injections daily (intensive therapy)
  • 730 received 1-2 insulin injections daily (conventional therapy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What were the conclusions of the [type 1] diabetes control & complications trial?

A

Primary prevention cohort:
- Fewer pts in in intensive therapy developed retinopathy

Secondary intervention cohort:
- Fewer pts in in intensive therapy had sustained progression of retinopathy

Overall, intensive therapy reduced risk of:

  • development & sustained progression of retinopathy by 63%
  • severe retinopathy by 47%
  • microalbuniuria by 39%
  • albuminuria by 54%
  • clinical neuropathy at 5 years by 60%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What did the literature review by Sigal et al look at?

A

Evidence about prescription of exercise for diabetes patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What recommendations were made by Sigal et al for individuals with diabetes?

A
  • Program of at least 150 min/week of mod-vig PA & a healthful diet with modest energy restriction
  • PA distributed over at least 3 days/week with no more than 2 consecutive days without PA
  • Increased volumes of AP for increased weight loss
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What exercise guidelines were outlined Hordern et al’s statement?

A
  • Minimum of 210 min of mod intensity or 125 min of vig intensity exercise each week.
  • Combination of aerobic & resistance training
  • Aerobic & resistance training can be combined in one session
  • Exercise should be performed on at least 3 days each week with no
    more than 2 consecutive days without training
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What precautions & CIs were outlined Hordern et al’s statement?

A
  • Hypoglycaemia: self-monitor BGL
  • Cardiac risk: screen for risk factors
  • Peripheral neuropathy: Footwear, low impact exercises
  • Obesity: joint pain
  • PVD: may not be able to complete vig aerobic exercises with severe symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What did the study by Mendes et al 2016 look at?

A

Analysed guidelines & recommendations for exercise prescription for pts with T2DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What did the study by Mendes et al 2016 conclude?

A
  • 150 minutes (minimum) of accumulated aerobic exercise weekly @ mod-vig intensity (4-6 or 12/13 on the RPE scale) OR
  • 90 minutes (minimum) of vig intensity (7-8 or 14-17 on the RPE scale)
  • Spread over at least 3/7 with no more than 2 consecutive days off
  • Aerobic exercise may be done in 10 minute bouts throughout the day.
  • Resistance exercises 2/7
  • Flexibility exercises may complement other exercise types.
  • Exercise in diabetes improves glycaemic control, insulin sensitivity, body composition, BP and lipid profile while reducing other CV risk factors.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What did the UK prospective diabetes study look at?

A
  • Newly diagnosed pts with T2DM
  • Divided into overweight & non-overweight
  • Overweight: Randomly assigned intensive treatment with insulin, sulphonylurea or metformin, or conventional treatment with diet
  • Non-overweight: Randomly assigned intensive treatment with insulin or sulphonylurea, or conventional treatment with diet
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What did the UK prospective diabetes study find?

A

Conventional: Steady increase in FBG and HbA over 10 yrs

Intensive:

  • Initial decrease in FPG & HbA, then increase like conventional
  • Lower median HbA
  • Increase in weight by ~3.1kg
  • Increased risk hypoglycaemia

Both:
- 16% risk reduction for MI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What did the position statement by Inzucchi et al find about therapeutic options for T2DM?

A
  • Sodium-glucose cotransported 2 (SGLT2) inhibitors: Reduces glucose, HbA1c, albuminuria & weight
  • Thiazolidinediones: Weight gain, peripheral oedema, heart failure, fractures
  • Dipeptidyl peptidase 4 inhibitors: No side effects for CV by possibly for pancreas
  • Metformin: CV benefits, low cost, safe
How well did you know this?
1
Not at all
2
3
4
5
Perfectly